These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9167010)

  • 1. Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine.
    Amadori M; Volpe G; Defilippi P; Berneri C
    Biologicals; 1997 Mar; 25(1):65-73. PubMed ID: 9167010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems with BHK 21 cells.
    Brown F
    Dev Biol Stand; 1998; 93():85-8. PubMed ID: 9737382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic and phenotypic changes of BHK-21 cells grown in suspension cultures.
    Amadori M; Berneri C
    Cytotechnology; 1993; 11 Suppl 1():S106-8. PubMed ID: 7686770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The production of foot-and-mouth disease virus from BHK 21 C 13 cells grown on the surface of glass spheres.
    Spier RE; Whiteside JP
    Biotechnol Bioeng; 1976 May; 18(5):649-57. PubMed ID: 179634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of foot-and-mouth disease virus from BHK 21 C 13 cells grown on the surface of DEAE sephadex A50 beads.
    Spier RE; Whiteside JP
    Biotechnol Bioeng; 1976 May; 18(5):659-67. PubMed ID: 179635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of foot-and-mouth disease virus integrin receptor expression in tissues from naïve and infected cattle.
    O'Donnell V; Pacheco JM; Gregg D; Baxt B
    J Comp Pathol; 2009; 141(2-3):98-112. PubMed ID: 19515380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period.
    Radlett PJ; Pay TW; Garland AJ
    Dev Biol Stand; 1985; 60():163-70. PubMed ID: 2995169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of yields of foot--and--mouth disease virus from BHK monolayer and suspension cells.
    Spier RE
    Dev Biol Stand; 1976; 35():73-8. PubMed ID: 198316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of penetration and intracellular localization of incoming parental foot and mouth disease virus (FMDV) in BHK cells.
    Rossetti OL; Campos RH; Carrillo EC; de Torres RA
    Microbiologica; 1983 Jan; 6(1):35-44. PubMed ID: 6302446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined method (suspension-monolayer) of preparing an inactivated foot-and-mouth disease vaccine].
    Genov I; Tivchev G; Veleva E; Tekerlekov P; Shopov I
    Vet Med Nauki; 1981; 18(5):57-63. PubMed ID: 6275604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers.
    Vagnozzi A; Stein DA; Iversen PL; Rieder E
    J Virol; 2007 Nov; 81(21):11669-80. PubMed ID: 17728223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of capsid coding region of foot-and-mouth disease virus type A vaccine strain during serial passages in BHK-21 adherent and suspension cells.
    Anil KU; Sreenivasa BP; Mohapatra JK; Hosamani M; Kumar R; Venkataramanan R
    Biologicals; 2012 Nov; 40(6):426-30. PubMed ID: 23084588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspension cells. Correlation with cell ploidy alterations and abnormal expression of the alpha 5 beta 1 integrin.
    Amadori M; Berneri C; Archetti IL
    Vaccine; 1994 Feb; 12(2):159-66. PubMed ID: 7511862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and control of BHK cells in inactivated foot-and-mouth disease vaccine production.
    Capstick PB; Telling RC; Garland AJ
    Prog Immunobiol Stand; 1967; 3():131-5. PubMed ID: 4314421
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with production of interferon and Japanese encephalitis vaccine in continuous cell lines.
    Peiwei G; Zhifen D; Zhongquan W
    Dev Biol Stand; 1989; 70():223-6. PubMed ID: 2474469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of recombination for the production of foot-and-mouth disease virus vaccine strains.
    McCahon D; King AM; Slade WR; Skinner HH; Haresnape J
    Dev Biol Stand; 1980; 46():223-30. PubMed ID: 6244999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial replacement of serum with peptone and lactalbumin hydrolysate for the production of foot-and-mouth disease vaccine in BHK-21 cells.
    Saha SN; Sen AK
    Acta Virol; 1989 Aug; 33(4):338-43. PubMed ID: 2574940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Developments in foot-and-mouth disease (FMD) vaccine production (author's transl)].
    Barteling SJ
    Tijdschr Diergeneeskd; 1980 Sep; 105(17):695-8. PubMed ID: 6252656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.